Chinese medical equipment’s provider Neusoft Medical Systems Co Ltd has signed an agreement to integrate DiA Imaging Analysis Ltd's breakthrough automated software tools into its own ultrasound product range.

The agreement will bring cardiac automated tools to Neusoft’s ultrasound products and provide its customers with quick, accurate and reproducible imaging analysis of the heart.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Based in Israel, DiA Imaging Analysis provides next-generation medical imaging analysis technology.

Indian oncology company OncoStem Diagnostics Pvt Ltd has closed a venture financing round led by Sequoia Capital to raise $6m. The funds will be used for research and development (R&D), improving tests for oral, brain and colon cancer, in addition to automating the tests.

The proceeds will also be used for expanding the company’s presence in India and to introduce the test in new markets.

"The agreement will bring cardiac automated tools to Neusoft’s ultrasound products and provide its customers with quick, accurate and reproducible imaging analysis of the heart."

French company Visiomed Group has raised €1m ($1.18m) in gross proceeds through the private placement of convertible bonds.

L1 Capital Corp subscribed to the bonds offering.

Chinese company Double Medical Technology Inc is planning for an initial public offering (IPO) of shares to be listed on the Shenzhen Stock Exchange.

CITIC Securities Co Ltd is the underwriter for the IPO.